Drug or treatment
Tirabrutinib clinical trials
As of November 12, 2026, Find a Trial lists 2 clinical trials of Tirabrutinib that are recruiting, at sites in 8 countries (most in Japan (1), Australia (1), Brazil (1)). By phase: Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 8Countries
All recruiting trials (2)
-
Tirabrutinib versus rituximab plus temozolomide for relapsed or refractory primary central nervous system lymphoma
This trial tests whether the oral drug tirabrutinib works better alone than the combination of rituximab and temozolomide for people with relapsed or refractory primary CNS lymphoma.
-
Tirabrutinib maintenance therapy for patients with primary CNS lymphoma in remission
This study is testing if taking tirabrutinib every day can help people with primary CNS lymphoma stay in remission longer after their initial treatment.
Quick answers
How many clinical trials of Tirabrutinib are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in Japan (1 trial), Australia (1 trial), Brazil (1 trial), Czechia (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.